Reduction of cytotoxicity to normal tissues by new regimens of cell-cycle phase-specific drugs

From MaRDI portal
Publication:1109704

DOI10.1016/0025-5564(88)90002-8zbMath0655.92004OpenAlexW2090180109MaRDI QIDQ1109704

B. Schechter, R. Arnon, Zvia Agur

Publication date: 1988

Published in: Mathematical Biosciences (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/0025-5564(88)90002-8



Related Items

Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999), A mathematical model of cycle-specific chemotherapy, A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment, Analysis of resonance chemotherapy in leukemia treatment via multi-staged population balance models, The role of initial tumor biomass size in a mathematical model of periodically pulsed chemotherapy, About a generalized model of lymphoma, Optimization of interleukin-21 immunotherapeutic strategies, THREE TYPES OF SIMPLE DDE'S DESCRIBING TUMOR GROWTH, A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs, A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin \(A\), USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS, Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement, Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapy, LONG-RANGE PREDICTABILITY IN MODELS OF CELL POPULATIONS SUBJECTED TO PHASE-SPECIFIC DRUGS: GROWTH-RATE APPROXIMATION USING PROPERTIES OF POSITIVE COMPACT OPERATORS, A mathematical model to study the effects of drug resistance and vasculature on the response of solid tumors to chemotherapy, Optimal control for a stochastic model of cancer chemotherapy



Cites Work